KEGG   DRUG: Olmesartan medoxomil and azelnidipine
Entry
D09594            Mixture   Drug                                   
Name
Olmesartan medoxomil and azelnidipine;
Rezaltas (TN)
Component
Olmesartan medoxomil [DR:D01204], Azelnidipine [DR:D01145]
Class
Cardiovascular agent
 DG01925  Renin-angiotensin system inhibitor
 DG03231  Antihypertensive
Metabolizing enzyme substrate
 DG01633  CYP3A/CYP3A4 substrate
  DG02913  CYP3A4 substrate
Remark
Therapeutic category: 2149
Product: D09594<JP>
Efficacy
Antihypertensive
Comment
Azelnidipine is primarily metabolized by CYP3A4.
Metabolism
Enzyme: CYP3A4 [HSA:1576]
Interaction
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 2  Agents affecting individual organs
  21  Cardiovascular agents
   214  Antihypertensives
    2149  Others
     D09594  Olmesartan medoxomil and azelnidipine
Drug groups [BR:br08330]
 Cardiovascular agent
  DG01925  Renin-angiotensin system inhibitor
   D09594  Olmesartan medoxomil and azelnidipine
  DG03231  Antihypertensive
   D09594  Olmesartan medoxomil and azelnidipine
 Metabolizing enzyme substrate
  DG01633  CYP3A/CYP3A4 substrate
   DG02913  CYP3A4 substrate
    D09594  Olmesartan medoxomil and azelnidipine
Drug classes [BR:br08332]
 Cardiovascular agent
  DG03231  Antihypertensive
   D09594  Olmesartan medoxomil and azelnidipine
Drug metabolizing enzymes and transporters [br08309.html]
 Drug metabolizing enzymes
  D09594
Other DBs
PubChem: 124490334
LinkDB

» Japanese version   » Back

DBGET integrated database retrieval system